ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1087

Rheumatology Clinic Smoking Cessation Protocol Markedly Increases Quit Line Referrals

Christie M. Bartels1, Edmond Ramly2, Daniel Panyard3, Diane Lauver4, Heather Johnson5, Zhanhai Li6, Emmanuel Sampene7, Megan Piper8 and Patrick McBride5, 1Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI, 2Industrial and Systems Engineering, University of Wisconsin College of Engineering, Madison, WI, 3Population Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin-Madison School of Nursing, Madison, WI, 5Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 6Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 7Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 8University of Wisconsin Center for Tobacco Research and Intervention, Madison, WI

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, quality improvement, Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and tobacco use

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Smoking predicts higher incidence, greater severity, and reduced treatment responses in rheumatoid arthritis, lupus, and spondyloarthritis. However, cessation advice and quit line referral occur in just 10% and 0.6% of rheumatology visits, respectively. Primary care staff protocols improve guideline-based care, and electronic referrals increase use of free, state tobacco quit lines by 13-fold. We sought to examine a similar staff protocol in rheumatology using electronic health record (EHR) tools to connect eligible patients to a free, state quit line.

Methods: We conducted a pre- post-analysis of EHR data (2012-16) including our 6-month Quit Connect project. During implementation, cessation experts and project staff provided an hour of Quit Connect protocol training to nurses and medical assistants at three rheumatology clinics. The protocol included EHR prompts to assess smoking status, 30-day readiness to quit or cut back, and willingness to try a quit line. EHR data measured process steps. Referral to the quit line (vs. our published baseline) was the primary outcome. The quit line reported patient outcomes. The IRB exempted this as standard of care with permission to publish.

Logistic regression models examined process measures and referrals pre- and post-protocol. Multivariable process models included age, sex, race, body mass index (BMI), socioeconomic status (SES; defined as ever receiving Medicaid), and comorbidity (Johns Hopkins Adjusted Clinical Groups (ACG) score).

Results: For 54,090 rheumatology visits, 4,601 (9%) reported current smoking. 4,078 pre-protocol visits with patients who smoke (2012-15) were compared to 523 visits after protocol implementation (2016). Documenting smoking status remained high (96 v. 97%). 30-day readiness to quit assessment rose from 3% to 80% post-protocol (Table 1, OR 120, 91-159). Among those asked, 29% reported being ready to quit. Of those ready, 76% had a referral to the state tobacco quit line compared to our pre- rate of 0.6% (OR 26, 6-106). When offered, 71% accepted referrals (54% of ready to quit; 13% of smokers).

Patients with higher comorbidity were less often ready to quit (ACG OR 0.6, 0.4-0.9 unadj.); older patients accepted fewer referrals (OR 0.8, 0.7-0.97 unadj. per 10 yrs.). Adjusted models did not change results.

Among 66 referred patients, 11 (17%) accepted counselling, nicotine replacement, and set a quit date, and 5 more reported a quit in process. Overall, 24% of referred patients set a quit date or reported a quit attempt.

Conclusion:   Our Quit Connect protocol for rheumatology staff increased quit line referrals over 20-fold. When asked, a third of patients were ready to quit and half agreed to referral. Given the importance of cessation to reduce immune and cardiopulmonary disease, future rheumatology studies should investigate cessation protocols to leverage quit lines, which are free in all states.


Disclosure: C. M. Bartels, Pfizer Inc, 2; E. Ramly, None; D. Panyard, None; D. Lauver, None; H. Johnson, None; Z. Li, None; E. Sampene, None; M. Piper, None; P. McBride, None.

To cite this abstract in AMA style:

Bartels CM, Ramly E, Panyard D, Lauver D, Johnson H, Li Z, Sampene E, Piper M, McBride P. Rheumatology Clinic Smoking Cessation Protocol Markedly Increases Quit Line Referrals [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/rheumatology-clinic-smoking-cessation-protocol-markedly-increases-quit-line-referrals/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatology-clinic-smoking-cessation-protocol-markedly-increases-quit-line-referrals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology